Apellis Pharmaceuticals, Inc. Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
VOTINGAGREEMENT
Apellis Pharmaceuticals, Inc.
Biotechnology
2015
Offer Letter, dated as of December 25, 20202, by and between the Registrant and Baumal Caroline
Apellis Pharmaceuticals, Inc.
2024
Sales Agreement, dated as of November 1, 2023, by and between Apellis Pharmaceuticals, Inc. and Cowen and Company, LLC
Sales Agreements
Apellis Pharmaceuticals, Inc.
2023
Underwriting Agreement, dated February 22, 2023, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
Apellis Pharmaceuticals, Inc.
2023
Form of Exchange Agreement
Exchange Agreements
Apellis Pharmaceuticals, Inc.
2022
Form of Exchange Agreement
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated March 23, 2022, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
2022
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
2022
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Apellis Pharmaceuticals, Inc.
2022
Offer Letter, dated as of April 20, 2020, by and between the Registrant and Nur Nicholson
Apellis Pharmaceuticals, Inc.
Biotechnology
2022
Offer Letter, dated as of November 16, 2018, by and between the Registrant and Adam Townsend
Apellis Pharmaceuticals, Inc.
Biotechnology
2022
Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated November 15, 2021, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Form of Exchange Agreement
Exchange Agreements
Apellis Pharmaceuticals, Inc.
2021
Amended and Restated Commercial Supply Agreement, dated March 10, 2021, by and between the Registrant, Apellis Switzerland GmbH and NOF Corporation
Supply Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
2021
Fourth Amendment to Lease, dated November 13, 2020, by and between Registrant and NWALP PHOP Property Owner LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
2021
Form of Exchange Agreement
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2021
Amendment No. 1 to 2017 Employee Stock Purchase Plan
Stock Agreements
Apellis Pharmaceuticals, Inc.
2020
Form of Capped Call Transaction Confirmation
Apellis Pharmaceuticals, Inc.
Biotechnology
2020
Description of Securities Registered Under Section 12 of the Exchange Act
Apellis Pharmaceuticals, Inc.
Biotechnology
2020
Underwriting Agreement, dated January 8, 2020, by and among the Company and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Evercore Group L.L.C
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
2020
Third Amendment to Lease, dated September 25, 2019, by and between Registrant and NWALP PHOP Property Owner LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
2019
Apellis Pharmaceuticals, Inc. Executive Separation Benefits and Retention Plan
Retention Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2019
Form of Capped Call Transaction Confirmation
Apellis Pharmaceuticals, Inc.
Biotechnology
2019
Indenture (including form of Note), dated as of September 16, 2019, by and between Apellis Pharmaceuticals, Inc and U.S. Bank National Association, as trustee
Indenture Agreements
Apellis Pharmaceuticals, Inc.
2019
Amendment, dated as of June 7, 2019, to the Development Funding Agreement, dated as of February 28, 2019 by and between the Registrant and SFJ Pharmaceuticals XI, L.P
Development Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
2019
Second Amendment to Lease, dated June 5, 2019, by and between Registrant and NWALP PHOP Property Owner LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2019
Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler
Apellis Pharmaceuticals, Inc.
2019
Development Funding Agreement, dated as of February 28, 2019 by and between the Registrant and SFJ Pharmaceuticals XI, L.P
Development Agreements
Apellis Pharmaceuticals, Inc.
2019
Standard Office Lease, dated as of March 29, 2019, by and between the Registrant and Geary-Market Investment Company, Ltd
Lease Agreements
Apellis Pharmaceuticals, Inc.
2019
Underwriting Agreement, dated March 6, 2019, by and among the Company and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
NY
2019
Fourth Addendum to Office Lease Agreement, dated as of July 2, 2018, by and between Registrant and Westwind Way Properties, LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
2018
First Amendment to Lease, dated July 25, 2018, by and between Registrant and NWALP PHOP Property Owner LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
2018
Form of Underwriting Agreement
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
2018
2017 Stock Incentive Plan
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2017
Summary of Non-Employee Director Compensation Program
Compensation Agreements
Apellis Pharmaceuticals, Inc.
2017
2017 Employee Stock Purchase Plan
Stock Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2017
Specimen stock certificate evidencing the shares of common stock
Stock Agreements
Apellis Pharmaceuticals, Inc.
2017
Form of Incentive Stock Option Agreement under 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
2017
Form of Nonstatutory Stock Option Agreement under 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
2017
Form of Director and Officer Indemnification Agreement
Indemnification Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2017
Form of Underwriting Agreement
Underwriting Agreements
Apellis Pharmaceuticals, Inc.
2017
Offer Letter, dated as of October 9, 2017, by and between the Registrant and Timothy Sullivan
Apellis Pharmaceuticals, Inc.
Biotechnology
MA
2017
Warrant to purchase shares of common stock issued to Golda Darty Partners S.A
Warrant Agreements
Apellis Pharmaceuticals, Inc.
2017
Warrant to purchase shares of common stock issued to Silicon Valley Bank
Warrant Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2017
Loan and Security Agreement, dated as of October 20, 2017, between the Registrant and Silicon Valley Bank
Loan Agreements
Apellis Pharmaceuticals, Inc.
2017
Asset Purchase Agreement, dated as of September 24, 2014, by and between the Registrant and Potentia Pharmaceuticals, Inc
Purchase Agreements
Apellis Pharmaceuticals, Inc.
2017
Investors Rights Agreement, dated as of August 7, 2017, among the Registrant and the other parties thereto
Investor Rights Agreements
Apellis Pharmaceuticals, Inc.
2017
Voting Agreement, dated as of September 8, 2015, between the Registrant and Potentia Pharmaceuticals, Inc
Voting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
2017
2010 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
2017
Form of Incentive Stock Option Grant Notice and Agreement under 2010 Equity Incentive Plan
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2017
Form of Nonstatutory Stock Option Grant Notice and Agreement under 2010 Equity Incentive Plan
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
2017
Patent License Agreement, dated as of March 28, 2008, by and between Apellis AG and The Trustees of the University of Pennsylvania, as assigned to the Registrant
License Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
PA
2017
Amended and Restated Patent License Agreement, dated as of March 28, 2008, by and between Potentia Pharmaceuticals, Inc. and The Trustees of the University of Pennsylvania, as...
License Agreements
Apellis Pharmaceuticals, Inc.
2017
Office Lease Agreement, dated as of October 21, 2010, by and between the Registrant and DHB Properties, LLC, as amended
Lease Agreements
Apellis Pharmaceuticals, Inc.
2017
Consulting Agreement, dated as of September 10, 2015, by and between the Registrant and Danforth Advisors, LLC, as amended
Consulting Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
MA
2017
Lease, dated as of April 27, 2017, by and between the Registrant and NWALP PHOP Property Owner, LLC
Lease Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
MA
2017
Offer Letter, dated as of March 7, 2017, by and between the Registrant and Steven Axon
Apellis Pharmaceuticals, Inc.
2017
SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM
Compensation Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
2015
ASSET PURCHASE AGREEMENT dated September 24, 2014 between APELLISPHARMACEUTICALS, INC. and POTENTIA PHARMACEUTICALS, INC. TABLE OF CONTENTS
Purchase Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2015
INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Apellis Pharmaceuticals, Inc.
2015
APELLIS PHARMACEUTICALS, INC. 2010 EQUITY INCENTIVE PLAN As adopted May 12, 2010. ARTICLE 1 PURPOSE
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2015
APELLIS PHARMACEUTICALS, INC. 2010 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2015
APELLIS PHARMACEUTICALS, INC. 2010 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE
Bonus & Incentive Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
DE
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITYof PENNSYLVANIA Patent...
Exchange Agreements
Apellis Pharmaceuticals, Inc.
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY OF PENNSYLVANIA Amended...
Exchange Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
PA
2015
BLUEGRASS EYE BUILDING OFFICE LEASE AGREEMENT BY AND BETWEEN DHBPROPERTIES. LLC, A KENTUCKY PROFESSIONAL SERVICE CORPORATION (LANDLORD) AND APELLISPHARMACUTICALS, INC. A DELAWARE...
Lease Agreements
Apellis Pharmaceuticals, Inc.
Biotechnology
KY
2015
CONSULTING AGREEMENT
Consulting Agreements
Apellis Pharmaceuticals, Inc.
2015